MHRA mulls codeine linctus P to POM switch amid ‘recreational’ use concerns
The medicines regulator has launched a month-long public consultation on whether to make the opioid cough medicine prescription-only, it has announced.
Codeine linctus may be reclassified to a prescription-only medication (POM), as the Medicines and Healthcare products Regulatory Agency (MHRA) today (July 18) announced the launch